CHICAGO, Nov. 7, 2024 /PRNewswire/ -- On September 23, 2024, Danone SA (OTCQX: DANOY) proposed to acquire Lifeway Foods (NASDAQ: LWAY) in a transaction valued at approximately $283 million, offering $25 per share in cash. However, on November 6, the Lifeway Foods Board of Directors rejected the offer, instead adopting a "poison pill" limited shareholder rights plan. Edward and Ludmila Smolyansky, significant shareholders and members of Lifeway Foods' founding family, released the following statement in response: "For nearly four decades, we have fostered Lifeway's growth with careful attention to what is best for the company's future. Today, we strongly support Danone's offer, which represents a substantial premium over Lifeway's recent share price and reflects their confidence in the growing U.S. kefir market — a category we helped build from the ground up. "As we approach one of most significant and closely watched earnings releases in Lifeway's history, we remain optimistic about the company's potential and believe that Danone's proposal presents a unique opportunity to enhance value for all shareholders. "We encourage the Lifeway board to carefully and in good faith reconsider Danone's offer and seize this opportunity to deliver lasting value to shareholders, employees, and consumers. CEO Julie Smolyansky and the board need to focus on the tangible, lucrative offer in front of them, not on futile distractions that waste valuable time and resources. The longer they wait, the more money they will leave on the table, to the detriment of all."Cision View original content:https://www.prnewswire.com/news-releases/edward-and-ludmila-smolyansky-support-danone-bid-to-acquire-lifeway-foods-nasdaq-lway-302299395.html SOURCE Edward and Ludmila Smolyansky View Comments
Edward and Ludmila Smolyansky Support Danone Bid to Acquire Lifeway Foods (NASDAQ: LWAY)
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...